| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 12/06/2012 | WO2012165916A2 Non-peptidyl polymer-insulin multimer and method for producing the same |
| 12/06/2012 | WO2012165915A2 Composition for treating diabetes comprising long-acting insulin conjugate and long-acting insulinotropic peptide conjugate |
| 12/06/2012 | WO2012165914A2 Novel diphenylmethane derivatives as sglt2 inhibitors |
| 12/06/2012 | WO2012165888A2 Composition for treating obesity and diabetes and for increasing muscle mass and improving capacity for exercise, comprising extracts of piper retrofractum vahl. fruits as active ingredients |
| 12/06/2012 | WO2012165735A1 Pharmaceutical composition containing mushroom mycelium rice extract for treating diabetes or obesity |
| 12/06/2012 | WO2012165547A1 Method for manufacturing pyrazole derivative |
| 12/06/2012 | WO2012165398A1 Cycloalkyloxybiaryl compound |
| 12/06/2012 | WO2012165345A1 Composition for preventing and/or ameliorating cancer-related irreversible metabolism disorders |
| 12/06/2012 | WO2012165314A1 Amide compound |
| 12/06/2012 | WO2012164071A1 Imidazole derivatives |
| 12/06/2012 | WO2012163990A1 Sglt-2 inhibitors for treating metabolic disorders in patients treated with neuroleptic agents |
| 12/06/2012 | WO2012163546A1 Pharmaceutical composition comprising dapagliflozin and cyclodextrin |
| 12/06/2012 | WO2012162796A1 Methods and compositions for enhancing fertility and/or inhibiting pregnancy failure and restoring glucose tolerance |
| 12/06/2012 | WO2012099381A3 Preparation method of intermediate of sitagliptin |
| 12/06/2012 | WO2012091425A3 Composition containing a 4-hydroxytamoxifen analog or the pharmaceutically acceptable salts thereof as an active ingredient for preventing or treating diseases associated with metabolic syndrome |
| 12/06/2012 | US20120310211 Phentermine liquid dosage form |
| 12/06/2012 | US20120309848 Novel uses of nonenal |
| 12/06/2012 | US20120309842 Processes for the preparation of cinacalcet |
| 12/06/2012 | US20120309839 Dosing regimes for trans-clomiphene |
| 12/06/2012 | US20120309834 Novel uses of adipic acid |
| 12/06/2012 | US20120309833 Novel bexarotene analogs |
| 12/06/2012 | US20120309829 Compositions including pyruvate for companion animals and methods of use thereof |
| 12/06/2012 | US20120309808 Compositions and methods for epigenetic modification of nucleic acid sequences |
| 12/06/2012 | US20120309799 Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient |
| 12/06/2012 | US20120309792 Tetrazole derivatives as nicotinic acetylcholine receptor modulators |
| 12/06/2012 | US20120309791 Novel compound for the treatment of diseases associated with amyloid or amyloid-like proteins |
| 12/06/2012 | US20120309786 3-amino-pyridine derivatives for the treatment of metabolic disorders |
| 12/06/2012 | US20120309772 Inhibitors of fatty acid uptake and methods of use |
| 12/06/2012 | US20120309769 N-benzylindole modulators of pparg |
| 12/06/2012 | US20120309759 Screening Method and Compounds for Modulating Telomerase Activity |
| 12/06/2012 | US20120309758 Modulators of atp-binding cassette transporters |
| 12/06/2012 | US20120309757 N-biphenylmethylindole modulators of pparg |
| 12/06/2012 | US20120309747 Protein kinase inhibitors |
| 12/06/2012 | US20120309746 Triazolopyridine compounds |
| 12/06/2012 | US20120309736 Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| 12/06/2012 | US20120309719 (22e)-2-methylene-26,27-cyclo-22-dehydro-1alpha-hydroxy-19-norvitamin d3 derivatives |
| 12/06/2012 | US20120309716 Motor Function Improver |
| 12/06/2012 | US20120309712 Compositions Comprising Dietary Fat Complexer and Methods for Their Use |
| 12/06/2012 | US20120309710 Compound sea cucumber preparation and manufacturing method thereof |
| 12/06/2012 | US20120309700 Development and evaluation of novel chinese materia medica preparations |
| 12/06/2012 | US20120309697 Methods of diagnosing and prognosing colonic polyps |
| 12/06/2012 | US20120309677 Methods for regulating blood glucose levels |
| 12/06/2012 | US20120308675 Compositions for reducing fat on the human body |
| 12/06/2012 | US20120308650 Modified alginates for cell encapsulation and cell therapy |
| 12/06/2012 | US20120308647 Use of mir-30e to treat vascular lesions |
| 12/06/2012 | US20120308644 Compositions for mucosal delivery of agents |
| 12/06/2012 | US20120308627 Liquid-filled protein-phosphatidic acid capsule dispersions |
| 12/06/2012 | US20120308625 A method for altering the flavor of a food product |
| 12/06/2012 | US20120308589 Sinomenine derivatives, synthetic methods and uses thereof |
| 12/06/2012 | US20120308588 Neprilysin inhibitors |
| 12/06/2012 | US20120308586 Composition based on extra virgin olive oils |
| 12/06/2012 | US20120308581 Compositions and methods for detecting tlr3 |
| 12/06/2012 | US20120308568 Pharmaceutical composition for inhibiting abnormal proliferation of cells |
| 12/06/2012 | US20120308564 Treatment of a metabolic disorder |
| 12/06/2012 | US20120308549 Process for production and purification of recombinant lysosomal alpha-mannosidase |
| 12/06/2012 | US20120308544 Substances and Methods for the Treatment of Lysosmal Storage Diseases |
| 12/06/2012 | US20120308543 Lipase Variants for Pharmaceutical Use |
| 12/06/2012 | US20120308541 Pharmaceutical composition for treating the gastrointestinal tract |
| 12/06/2012 | US20120308536 Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
| 12/06/2012 | US20120308525 Nutritional compositions including a high protein component and exogenous nucleotides |
| 12/06/2012 | US20120308524 Composition for use in the therapy of lactose intolerance or conditions arising from lactase deficiency |
| 12/06/2012 | US20120308518 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders |
| 12/06/2012 | US20120308514 Human antibodies that bind human il-12 and methods for producing |
| 12/06/2012 | US20120308511 Co-Therapy for Diabetic Conditions |
| 12/06/2012 | CA2837856A1 Composition for treating diabetes comprising long-acting insulin conjugate and long-acting insulinotropic peptide conjugate |
| 12/06/2012 | CA2837851A1 Non-peptidyl polymer-insulin multimer and method for producing the same |
| 12/06/2012 | CA2837710A1 Long-acting glp-1/glucagon receptor agonists |
| 12/06/2012 | CA2837627A1 Sglt-2 inhibitors for treating metabolic disorders in patients treated with neuroleptic agents |
| 12/06/2012 | CA2837517A1 Imidazole derivatives |
| 12/06/2012 | CA2837437A1 Oral formulations of mitochondrially-targeted antioxidants and their preparation and use |
| 12/06/2012 | CA2837359A1 Methods and compositions for enhancing fertility and/or inhibiting pregnancy failure and restoring glucose tolerance |
| 12/06/2012 | CA2837232A1 Pharmaceutical composition comprising dapagliflozin and cyclodextrin |
| 12/05/2012 | EP2530079A1 Phenyl c-glucoside derivatives, preparation methods and uses thereof |
| 12/05/2012 | EP2529742A1 Pharmaceutical composition comprising dapagliflozin and cyclodextrin |
| 12/05/2012 | EP2529736A1 Expression promoter for redox-related factor |
| 12/05/2012 | EP2528659A1 Methods for regulating blood glucose levels |
| 12/05/2012 | EP2528614A1 Methods of treating glucose metabolism disorders |
| 12/05/2012 | EP2528612A1 Methods of treating glucose metabolism disorders |
| 12/05/2012 | CN202568931U Novel compound capsule containing ferrous fumarate and folic acid |
| 12/05/2012 | CN202568930U Tablet capsule with repaglinide solid preparation and dimethyldiguanide solid preparation |
| 12/05/2012 | CN202568929U Tablet capsules containing rosiglitazone solid preparation and metformin solid preparation |
| 12/05/2012 | CN202568926U Tablet capsule filled with alogliptin solid preparation and pioglitazone solid preparation |
| 12/05/2012 | CN202568893U System for preparing multi-vitamin |
| 12/05/2012 | CN102812037A Macrocyclic Ghrelin Receptor Antagonists And Inverse Agonists And Methods Of Using The Same |
| 12/05/2012 | CN102812017A Pyrazine derivatives |
| 12/05/2012 | CN102812014A Novel Oxime Derivatives And Their Use As Allosteric Modulators Of Metabotropic Glutamate Receptors |
| 12/05/2012 | CN102812011A [1,5]-diazocin Derivatives |
| 12/05/2012 | CN102811731A Composition comprising a combination of at least one proteolytic enzyme and at least one lipolytic enzyme, for use in preventing triglyceride synthesis |
| 12/05/2012 | CN102811717A Nutritional composition |
| 12/05/2012 | CN102807678A Method for circularly and continuously extracting eucommia gum, eucommia seed oil, eucommia extractum and eucommia resin from eucommia seeds |
| 12/05/2012 | CN102807617A Antibodies to M-CSF |
| 12/05/2012 | CN102807613A Secreted protein with chemotactic activity and medicament usage thereof |
| 12/05/2012 | CN102807612A Polypeptide fragment and preparation method and application thereof |
| 12/05/2012 | CN102807568A Thiadiazole derivative DPP-IV (dipeptidyl peptidase IV) inhibitor |
| 12/05/2012 | CN102807558A Fluorine-containing dihydroindene amide compound used as protein kinase inhibitor |
| 12/05/2012 | CN102807548A Norathyriol crystal I and preparation method thereof |
| 12/05/2012 | CN102807530A Process for preparing amorphous rosuvastatin calcium free of impurities |
| 12/05/2012 | CN102807526A Preparation method and application of histone deacetylase inhibitor ZYJ-D08a and epimer thereof |
| 12/05/2012 | CN102805858A High-efficiency calcium supplement capsule and preparation method thereof |
| 12/05/2012 | CN102805857A Preparation method of compound amino acid (15) dipeptide (2) injecta |